Alzamend Neuro ALZN
NASDAQ ALZN
$1.73 -0.09 (-4.95%)
At close: Sep 30, 2026 · 4:00 PM EDT

Alzamend Neuro (ALZN) Debt Ratio (2024)

Updated

Alzamend Neuro's (ALZN) Debt Ratio stood at 0.48 in fiscal Q4 2024 (quarter ended Apr 30, 2024).

Analysis

Alzamend Neuro (ALZN) Debt Ratio (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 0.24
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 0.52
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 0.42
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 0.31
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 0.00
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 0.60
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 0.53
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Alzamend Neuro 8.35 Mn 8.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2024 0.48
API Access

Alzamend Neuro Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=ALZN&period=max&api_key=YOUR_API_KEY